![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://endpts.com/exclusive-members-of-congress-buy-and-sell-stocks-that-would-gain-from-bill-banning-china-biotech-companies/
https://endpts.com/bio-ceo-defends-the-organizations-about-face-on-the-biosecure-act/
https://endpts.com/wuxi-wants-to-regain-client-confidence-amid-claims-of-ip-transfer-to-chinese-authorities/
https://endpts.com/drug-and-biotech-companies-join-lobbying-push-on-china-bill-as-scrutiny-of-wuxi-continues/
https://endpts.com/wuxi-builds-out-lobbying-bench-amid-legislative-effort-to-blacklist-company/
https://endpts.com/additional-drugmakers-flag-risks-of-working-with-wuxi-amid-heightened-us-scrutiny/
https://endpts.com/lead-house-sponsor-of-wuxi-linked-bill-to-leave-congress-early/
https://www.prnewswire.com/news-releases/wuxi-apptec-revenue-surpassed-rmb40-billion-in-2023-and-adjusted-non-ifrs-net-profit-exceeded-rmb10-billion-for-the-first-time-302091492.html
https://endpts.com/wuxi-apptecs-2023-sales-largely-reliant-on-the-us-report-says/
https://www.reuters.com/business/healthcare-pharmaceuticals/biotech-trade-association-split-with-chinas-wuxi-apptec-2024-03-13/